PTC Inc.: Oppenheimer cuts to Perform from Outperform
PTC•Oppenheimer cut its rating on PTC Inc. to Perform from Outperform.
Related News
GSK-backed ViiV says phase IIIb CROWN trial shows Cabenuva beats daily oral HIV therapy in viral suppression
GSK•
Firy to redeem remaining $49.70 million of 10.25% secured notes due 2026
FIRY•
LiqTech wins first commercial aquatics order in Finland for Helsinki hotel pool
LIQT•
INmune Bio to attend 2026 Maxim Growth Summit
INMB•
Airbnb says Gen Z Halloween weekend stay searches jump nearly 45%
ABNB•